PharmaShots | Incisive News in 3 Shots

Subscribe Now

chronic idiopathic urticaria

Novartis's Xolair (omalizumab) Prefilled Syringe for Self-Injection Receives the US FDA's Approval Across All Indications

Novartis's Xolair (omalizumab) Prefilled Syringe for Self-Injection Receives the US FDA's Approval Across All Indications

April 13, 2021

PharmaShots Interview: Genentech's Ted Omachi Shares Insights on Xolair (omalizumab) PFS

PharmaShots Interview: Genentech's Ted Omachi Shares Insights on Xolair (omalizumab) PFS

September 7, 2020

Roche Reports the US FDA's Acceptance of sBLA for Xolair (omalizumab) Prefilled Syringe for Self-Administration Across All Indications

Roche Reports the US FDA's Acceptance of sBLA for Xolair (omalizumab) Prefilled Syringe for Self-Administration Across All Indicat...

August 13, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us